PipelinePharma Logo

polymyxin b Injection 500000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21437

Established in 1996, this Manufacturer is a WHO-GMP and ISO-certified CTD dossier owner and manufacturer, employing between 101 to 250 professionals. As a GMP manufacturer, it operates dedicated production lines for cephalosporins, beta-lactam, penam, general dry powder injections, ophthalmic solutions, and liquid injectables in ampoules, vials, pre-filled syringes, and dental cartridges. With a portfolio exceeding 250 formulations, the Manufacturer exports products to over 44 countries and regions worldwide. As a CTD dossier owner and manufacturer, it upholds stringent GMP standards across all operations. Committed to global health, this GMP manufacturer continues to expand its presence in regulated markets.

Manufacturer usually replies in 8 days

Polymyxin B is an antibiotic used to treat bacterial infections, such as meningitis, pneumonia, sepsis. Although manufacturing companies use polymyxin B as a standalone drug, it is more commonly used in combination drug formulations, along with other active ingredients such as lidocaine, neomycin, bacitracin, diperodon, hydrocortisone, as well as many others. Polymyxin B suppliers market the standalone medication in the form of powders for injectable solutions. In medical use for over 50 years, polymyxin B has since become included in the WHO’s list of Essential Medicines that contains the most important drugs recommended for a basic health system. Polymyxin B suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified polymyxin B manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.